Publication | Open Access

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Hematological MalignancyRadiation OncologyMedicineImmunologyHematologyMyeloid NeoplasiaMultiple MyelomaImmunotherapyOncologyCell TransplantationAutologous Stem-cell TransplantationHealth Sciences